A retrospective, multicenter study of individual patient data to determine the extent of the variability in low-density lipoprotein-cholesterol reduction in response to inclisiran administration
Latest Information Update: 07 Oct 2022
At a glance
- Drugs Inclisiran (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
Most Recent Events
- 07 Oct 2022 New trial record
- 29 Aug 2022 Results presented at the ESC Congress 2022 - Annual Congress of the European Society of Cardiology